Method of detection of initial recurrence of stage II/III cutaneous melanoma: Analysis of the utility of follow-up staging

Annals of Surgical Oncology

Volumn 16, Issue 4, 2009, Pages 941-947

  Meyers, Michael O ^a   Yeh, Jen Jen ^a   Frank, Jill ^a   Long, Patricia ^a   Deal, Allison M ^a   Amos, Keith D ^a   Ollila, David W ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; YOUNG ADULT;

EID: 62149150287     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0238-y     Document Type: Article

References (25)

1. CR Shumate MM Urist WA Maddox 1995 Melanoma recurrence surveillance. Patient or physician based? Ann Surg 221 566 9
2. WJ Poo-Hwu S Ariyan L Lamb 1999 Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma Cancer 86 2252 8
3. C Garbe A Paul H Kohler-Spath 2003 Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol 21 520 9
4. AB Francken E Bastiaannet HJ Hoekstra 2005 Follow-up in patients with localised primary cutaneous melanoma Lancet Oncol 6 608 21
5. AB Francken HM Shaw NA Accortt 2007 Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines Ann Surg Oncol 14 1924 33
6. OE Nieweg BB Kroon 2006 The conundrum of follow-up: should it be abandoned? Surg Oncol Clin N Am 15 319 30
7. M Weiss CL Loprinzi ET Creagan 1995 Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas JAMA 274 1703 5
8. TJ Dicker GM Kavanagh RM Herd 1999 A rational approach to melanoma follow-up in patients with primary cutaneous melanoma Scottish Melanoma Group. Br J Dermatol 140 249 54
9. Cutaneous malignant melanoma. ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2007;18(Suppl 2):ii71-3.
10. U Hofmann M Szedlak W Rittgen 2002 Primary staging and follow-up in melanoma patients-monocenter evaluation of methods, costs and patient survival Br J Cancer 87 151 7
11. National Comprehensive Cancer Network. Melanoma: clinical practice guidelines in oncology. Available at: http://www.nccn.org/professionals/ physician-gls/PDF/melanoma.pdf. Accessed March 7, 2008.
12. SM Swetter LA Carroll DL Johnson 2002 Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients Ann Surg Oncol 9 646 53
13. KP Friedman RL Wahl 2004 Clinical use of positron emission tomography in the management of cutaneous melanoma Semin Nucl Med 34 242 53
14. G Antoch N Saoudi H Kuehl 2004 Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol 22 4357 68
15. 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients J Clin Oncol 24 1178 87
16. PB Clark V Soo J Kraas 2006 Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma Arch Surg 141 284 8
17. M Yancovitz N Finelt MA Warycha 2007 Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma Cancer 110 1107 14
18. Centers for Medicare and Medicaid Services. Available at: http://www.cms.hhs.gov/PFSlookup/. Accessed September 22, 2008.
19. Francken AB, Accortt NA, Shaw HM, et al. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Ann Surg Oncol. 2008. DOI: 10.1245/s10434-007-9717-9
20. S Fusi S Ariyan A Sternlicht 1993 Data on first recurrence after treatment for malignant melanoma in a large patient population Plast Reconstr Surg 91 94 8
21. AB Francken JF Thompson E Bastiaannet 2008 Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up Ned Tijdschr Geneeskd 152 557 62
22. Buzzell RA, Zitelli JA. Favorable prognostic factors in recurrent and metastatic melanoma. J Am Acad Dermatol. 1996;34(5 Pt 1):798-803.
23. DW Ollila 2006 Complete metastasectomy in patients with stage IV metastatic melanoma Lancet Oncol 7 919 24
24. GQ Phan P Attia SM Steinberg 2001 Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma J Clin Oncol 19 3477 82
25. R Kaufmann K Spieth U Leiter 2005 Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group J Clin Oncol 23 9001 7